Patel Amour, Prowle John R, Ackland Gareth L
William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK.
Clin Kidney J. 2017 Jun;10(3):348-356. doi: 10.1093/ckj/sfw118. Epub 2017 Jan 12.
The role of goal-directed therapy (GDT) in preventing creatinine rise following noncardiac surgery is unclear. We performed a post-hoc analysis of a randomized controlled trial to assess the relationship between postoperative optimization of oxygen delivery and development of acute kidney injury (AKI)/creatinine rise following noncardiac surgery. Patients were randomly assigned immediately postoperatively to receive either fluid and/or dobutamine therapy to maintain/restore their preoperative oxygen delivery, or protocolized standard care (oxygen delivery only recorded). Primary end point was serial changes in postoperative creatinine within 48 h postoperatively. Secondary outcomes were development of AKI (KDIGO criteria) and minimal creatinine rise (MCR; no decline from preoperative creatinine), related to all-cause morbidity and length of stay. Postoperative reductions in serum creatinine were similar (P = 0.76) in patients randomized to GDT [10 µmol/L (95% confidence interval, CI: 17 to -1); = 95] or protocolized care [8 µmol/L (95% CI: 17 to -6); = 92]. Postoperative haemodynamic management was not associated with the development of MCR [78/187 (41.7%)] or AKI [13/187; (7.0%)]. Intraoperative requirement for norepinephrine was more likely in patients who developed postoperative rises in creatinine [relative risk (RR): 1.66 (95% CI: 1.04-2.67); P = 0.04], despite similar volumes of intraoperative fluid being administered. Persistently higher lactate during the intervention period was associated with AKI (mean difference: 1.15 mmol/L (95% CI: 0.48-1.81); P = 0.01]. Prolonged hospital stay was associated with AKI but not MCR [RR: 2.71 (95% CI: 1.51-4.87); P = 0.0008]. These data provide further insights into how perioperative haemodynamic alterations relate to postoperative increases in creatinine once systemic inflammation is established.
目标导向治疗(GDT)在预防非心脏手术后肌酐升高方面的作用尚不清楚。我们对一项随机对照试验进行了事后分析,以评估非心脏手术后优化氧输送与急性肾损伤(AKI)/肌酐升高之间的关系。患者在术后立即被随机分配接受液体和/或多巴酚丁胺治疗,以维持/恢复术前的氧输送,或接受标准化常规治疗(仅记录氧输送情况)。主要终点是术后48小时内肌酐的系列变化。次要结局是AKI的发生(根据KDIGO标准)以及最小肌酐升高(MCR;肌酐水平未低于术前水平),以及与全因发病率和住院时间的关系。随机接受GDT治疗的患者[10微摩尔/升(95%置信区间,CI:17至 -1);n = 95]和接受标准化治疗的患者[8微摩尔/升(95%CI:17至 -6);n = 92]术后血清肌酐的降低情况相似(P = 0.76)。术后血流动力学管理与MCR[78/187(41.7%)]或AKI[13/187;(7.0%)]的发生无关。尽管术中输注的液体量相似,但术后肌酐升高的患者术中更有可能需要去甲肾上腺素[相对风险(RR):1.66(95%CI:1.04 - 2.67);P = 0.04]。干预期间持续较高的乳酸水平与AKI相关(平均差异:1.15毫摩尔/升(95%CI:0.48 - 1.81);P = 0.01)。住院时间延长与AKI相关,但与MCR无关[RR:2.71(95%CI:1.51 - 4.87);P = 0.0008]。这些数据进一步揭示了一旦全身炎症确立,围手术期血流动力学改变与术后肌酐升高之间的关系。